Journals / Turkish Neurosurgery / 2020 / Cilt: 30 - Sayı: 4

miR-24 Reduces Serum Lipid Levels and Inhibits Brain Tissue Cells Apoptosis of Rats with Cerebral Infarction

Pages
483–490
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

TC, TG and HDL-C levels of the MCAO and miR-24 antagomir groups were higher thanthose of normal and sham groups (p<0.05).Compared with the MCAO group, increased relative miR-24 expression (p<0.05) anddecreased TC, TG and HDL-C levels,cerebral infarction area percentage, number of apoptotic cells and caspase-3 expression(p<0.05) were found in themiR-24 agomir group, contrasting with theobservations from the miR-24 antagomir group.CONCLUSION: miR-24 reduced serum TCH, HDL and TG levels and inhibited brain tissue cell apoptosis in rats with cerebralinfarction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To study miR-24 effects on cerebral infarction in rats.MATERIAL and METHODS: A rat middle cerebral artery occlusion model (MCAO) was constructed.
📊
Key Findings & Data:Intracerebroventricularstereotactic injection of miR-24 agomir/antagomir was performed in the rat MCAO model.
💡
Conclusion & Impact:TC, TG and HDL-C levels of the MCAO and miR-24 antagomir groups were higher thanthose of normal and sham groups (p<0.05).Compared with the MCAO group, increased relative miR-24 expression (p<0.05) anddecreased TC, TG and HDL-C levels,cerebral infarction area percentage, number of apoptotic cells and caspase-3 expression(p<0.05) were found in themiR-24 agomir group, contrasting with theobservations from the miR-24 antagomir group.CONCLUSION: miR-24 reduced serum TCH, HDL and TG levels and inhibited brain tissue cell apoptosis in rats with cerebralinfarction.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: To study miR-24 effects on cerebral infarction in rats.MATERIAL and METHODS: A rat middle cerebral artery occlusion model (MCAO) was constructed. Intracerebroventricularstereotactic injection of miR-24 agomir/antagomir was performed in the rat MCAO model. According to different experiences,rats were divided into normal, sham, MCAO, miR-24 agomir and miR-24 antagomir groups. Serum TCH, HDL and TG levels weredetected.RESULTS: Comparingthe normal and sham groups, we observed decreased relative miR-24 expression (p<0.05) and increasedcerebral infarction area percentage, apoptotic cells and relative caspase-3 protein expression (p<0.05) in theMCAO, miR-24agomirand miR-24 antagomir groups. TC, TG and HDL-C levels of the MCAO and miR-24 antagomir groups were higher thanthose of normal and sham groups (p<0.05).Compared with the MCAO group, increased relative miR-24 expression (p<0.05) anddecreased TC, TG and HDL-C levels,cerebral infarction area percentage, number of apoptotic cells and caspase-3 expression(p<0.05) were found in themiR-24 agomir group, contrasting with theobservations from the miR-24 antagomir group.CONCLUSION: miR-24 reduced serum TCH, HDL and TG levels and inhibited brain tissue cell apoptosis in rats with cerebralinfarction.

🔖

Cite This Article

JIANG, Q., SHEN, D., WANG, Y., HUANG, D., WANG, Z. (2020). miR-24 Reduces Serum Lipid Levels and Inhibits Brain Tissue Cells Apoptosis of Rats with Cerebral Infarction. Turkish Neurosurgery, Cilt: 30 - Sayı: 4, 483–490. https://ajindex.com/articles/405261

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Chen HH, Hong-Hua LI, Lin L: Research on hypertension, diabetes, hyperlipidemia and endothelial dysfunction in patients with cerebral infarction. Journal of Brain & Nervous Diseases 2013 2. Chen W, Ou HS: Regulation of miR-24 on vascular endothelial cell function and its role in the development of cardiovascular disease. Sheng Li Xue Bao 68(2):201-206, 2016 3. Deng X, Liu Y, Luo M, Wu J, Ma R, Wan Q: Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus. Oncotarget 8: 63038-63046, 2017 4. Du M, Shi D, Lin Y, Li P, Chu H, Qin C, Yin C, Zhang Z, Wang M: Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep 5:10437, 2015 5. Fei Z, Le YG, Fan JC, Lin X: LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3p. Journal of Cellular Biochemistry 2017 6. Hurr C, Patik JC, Kim K, Brothers RM: Blunted cerebral vascular responsiveness to hypercapnia in obese individuals. Exp Physiol 102(10):1300-1308, 2017 7. Irani S, Pan X, Peck BCE, Iqbal J, Sethupathy P, Hussain MM: MicroRNA-30c mimic mitigates hypercholesterolemia and atherosclerosis in mice. J Biol Chem 291(35):18397-18409, 2016 8. Jackson KL, Marques FZ, Watson AM, Palmarigo K, Nguyenhuu TP, Morris BJ, Charchar FJ, Davern PJ, Head GA: A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Hypertension 62(4):775-781, 2013 9. Ji W, Sun B, Su C: Targeting MicroRNAs in cancer gene therapy. Genes 8: 21, 2017 10. Li W, Jin C, Vaidya A, Wu Y, Rexrode K, Zheng X, Gurol ME, Ma C, Wu S, Gao X: Blood pressure trajectories and the risk of intracerebral hemorrhage and cerebral infarction: A prospective study. Hypertension 70(3):508-514, 2017 11. Liu J, Zhu Y, Wu Y, Liu Y, Teng Z, Hao Y: Association of carotid atherosclerosis and recurrent cerebral infarction in the Chinese population: A meta-analysis. Neuropsychiatr Dis Treat 13:527- 533, 2017 12. Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84-91, 1989 13. Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martínez C, Ricart W, Rieusset J: Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Ca